QIAGEN to continue successful growth strategy focused on execution and greater value creation after voluntary public takeover offer falls short

/in /by

• Tender offer acceptance of 47% did not reach minimum threshold of 66.67% • QIAGEN Supervisory Board and Managing Board respect the views of shareholders • Focus on execution with strong outlook for 2020 and 2021, QIAGEN to continue strategy of creating value through Sample to Insight portfolio for growing molecular testing needs • QIAGEN […]

Read more →

Thermo Fisher Scientific Announces Results of Offer to Acquire QIAGEN, Lapse of Offer and Termination of Acquisition Agreement

/in /by

WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its offer to acquire all of the ordinary shares of QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has lapsed. Based on information provided by the settlement agents for the offer, Deutsche Bank Aktiengesellschaft and American Stock […]

Read more →

Sale of ZEISS iTrap

/in , /by

Agreement between ZEISS and Atlas Copco First Transfer of a Portfolio Element of ZEISS Ventures OBERKOCHEN, Germany / NACKA, Sweden / Semiconductor Manufacturing Technology Atlas Copco Group, a Sweden-based provider of industrial productivity solutions has acquired iTrap® mass spectrometry technology from ZEISS. The business will become part of the Semiconductor Chamber Solutions Division in Atlas […]

Read more →

Atlas Copco has acquired a technology for process diagnostics and control in the semiconductor industry

/in , /by

Nacka, Sweden, August 4, 2020: Atlas Copco has acquired the technology and operating assets of iTrap. The iTrap is an ion trap mass spectrometer instrument capable of highly sensitive real time gas analysis. The instrument is used for diagnostics or process control in semiconductor process chambers. The business is located in Oberkochen, in southern Germany, […]

Read more →

Proposed Acquisition and Placing to raise a minimum of £13 million

/in , , , , , /by

Manchester, UK: Yourgene Health plc (AIM: YGEN), the international molecular diagnostics group, today announces a proposed placing (the “Placing”) of new ordinary shares of 0.1 pence each (“Ordinary Shares”) in the capital of the Company (the “Placing Shares”) at a price of 17 pence per share (the “Placing Price”) to raise a minimum of £13 million. The […]

Read more →

Smiths Detection completes acquisition of PathSensors

/in , /by

Smiths Detection, a global leader in detection and screening technologies, today confirmed that it has completed the acquisition of PathSensors, a leading bio-technology solutions and environmental-testing company, based in Baltimore, MD, USA. The acquisition strengthens Smiths Detection’s biological-detection capabilities to detect pathogens for broad end-market applications, including in food and agriculture safety. “We are pleased […]

Read more →

Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement

/in /by

— Offer price increased from €39.00 to €43.00 per QIAGEN share in cash — Minimum acceptance threshold lowered from 75% to 66.67% of outstanding QIAGEN shares — QIAGEN Supervisory and Managing Boards reaffirm unanimous recommendation that QIAGEN shareholders tender all of their QIAGEN shares WALTHAM, Mass. and VENLO, The Netherlands — Thermo Fisher Scientific Inc. […]

Read more →

Illumina Acquires Enancio’s Compression Software

/in , , , /by

Reduces genomic data storage and transfer costs associated with the data deluge In 2019, the volume of genomic data generated by Illumina’s global installed base of more than 15,000 sequencing systems increased more than 50 percent year-over-year, to 150 petabases. That is the equivalent of 500 years of continuous video recordings in high definition. This […]

Read more →